Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWarren J. Gasper, MD
About this trial
This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.
Eligibility criteria
Qualifiers
greater than or equal to 6 cm in diameter in men,
greater than or equal to 5.5 cm in diameter in women,
and/or larger than 5 cm in diameter and enlarging at a rate of more than 5 mm/year,
and/or iliac aneurysms larger than 4 cm in diameter.
Disqualifiers
Free rupture of the aneurysm.
Pregnancy.
Known allergy to Nitinol, stainless steel, or polyester.
Unwillingness or inability to comply with the follow up schedule.
Trial design
Treatments tested in this trial
- Endovascular Branched Stent-Graft
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Warren J. Gasper, MD
Lead sponsor
University of California, San Francisco
Sponsor institution
Source ClinicalTrials.gov